These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 31899825)
1. LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer. Liu L; Zhan Y; Huang Y; Huang L J Oral Pathol Med; 2020 Mar; 49(3):243-252. PubMed ID: 31899825 [TBL] [Abstract][Full Text] [Related]
2. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer. Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387 [TBL] [Abstract][Full Text] [Related]
3. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis. Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e. Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696 [TBL] [Abstract][Full Text] [Related]
5. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1. Li H; Jiang J J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a. Xu L; Hou TJ; Yang P Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis. Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989 [TBL] [Abstract][Full Text] [Related]
8. FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis. Guo S; Huang B; You Z; Luo Z; Xu D; Zhang J; Lin J BMC Oral Health; 2024 May; 24(1):625. PubMed ID: 38807101 [TBL] [Abstract][Full Text] [Related]
9. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p. Aichen Z; Kun W; Xiaochun S; Lingling T Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163 [TBL] [Abstract][Full Text] [Related]
10. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma. Cao X; Luan K; Yang J; Huang Y Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα. Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma. Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478 [TBL] [Abstract][Full Text] [Related]
13. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling. Yang Y; Dong MH; Hu HM; Min QH; Xiao L Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis. Lu T; Liu H; You G Int J Mol Med; 2018 Dec; 42(6):3291-3299. PubMed ID: 30280186 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1. Fan Y; Li H; Yu Z; Dong W; Cui X; Ma J; Li S Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31919528 [TBL] [Abstract][Full Text] [Related]
16. The potential influence of long non-coding RNA PRKG1-AS1 on oral squamous cell carcinoma: A comprehensive study based on bioinformatics and in vitro validation. Wu T; Zhang SY; Dong WJ; Wang M; Sun YB J Oral Pathol Med; 2020 May; 49(5):409-416. PubMed ID: 31788859 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway. Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression. Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma. Wei X; Li Z; Zheng H; Li X; Lin Y; Yang H; Shen Y Funct Integr Genomics; 2024 Sep; 24(5):158. PubMed ID: 39249547 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma. Feng H; Zhang X; Lai W; Wang J Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]